Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214252 · ClinicalTrials.gov registry record
A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects
A clinical trial of Abdominal Wall Defects, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 343
- Enrollment target
- 1
- Study location
NCT01214252 is a study of Abdominal Wall Defects that has completed, run by Medtronic - MITG. The registered enrollment target is 343 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01214252, a study of Abdominal Wall Defects, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 343 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate short, mid and long term clinical outcomes associated with the use of Permacol in the treatment of abdominal wall defects.
Conditions Studied
Interventions
- DEVICE Permacol Surgical Implant
Study Locations (1)
Massachusetts
- Annie Choi - Bedford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01214252
The ClinicalTrials.gov registry entry for NCT01214252 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Wall Defects appearing as the primary indexed condition, and to 1 intervention - of which Permacol Surgical Implant is the first listed.
NCT01214252 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01214252 about?
NCT01214252 is a clinical study titled "A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects". To evaluate short, mid and long term clinical outcomes associated with the use of Permacol in the treatment of abdominal wall defects.
What is the current status of trial NCT01214252?
This trial is currently completed. The enrollment target is 343 participants. The study started on 2010-10. Estimated completion is 2012-01.
What conditions does trial NCT01214252 study?
This clinical trial studies the following conditions: Abdominal Wall Defects.
What interventions are being tested in trial NCT01214252?
The interventions under investigation include: Permacol Surgical Implant (DEVICE).
Who is sponsoring clinical trial NCT01214252?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01214252 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.